Journal
TRENDS IN BIOTECHNOLOGY
Volume 32, Issue 5, Pages 263-270Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2014.03.001
Keywords
nanobody; recombinant protein production; antibody fragment; GFP-binding protein; plant production platform; yeast production platform
Categories
Funding
- Agency for Innovation by Science and Technology (IWT)
Ask authors/readers for more resources
Since the serendipitous discovery 20 years ago of bona fide camelid heavy-chain antibodies, their single-domain antigen-binding fragments, known as VHHs or nanobodies, have received a progressively growing interest. As a result of the beneficial properties of these stable recombinant entities, they are currently highly valued proteins for multiple applications, including fundamental research, diagnostics, and therapeutics. Today, with the original patents expiring, even more academic and industrial groups are expected to explore innovative VHH applications. Here, we provide a thorough overview of novel implementations of VHHs as research and diagnostic tools, and of the recently evaluated production platforms for several VHHs and VHH-derived antibody formats.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available